These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 8710773

  • 1. Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease.
    Heinonen S, Ryynänen M, Kirkinen P, Penttilä I, Syrjänen K, Seppälä M, Saarikoski S.
    Prenat Diagn; 1996 Mar; 16(3):207-13. PubMed ID: 8710773
    [Abstract] [Full Text] [Related]

  • 2. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU, Damm P, Tabor A, Pedersen JF, Mølsted-Pedersen L.
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [Abstract] [Full Text] [Related]

  • 3. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B, Sohn C, Beldermann F, Bastert G.
    Zentralbl Gynakol; 1997 Dec; 119(11):560-6. PubMed ID: 9480612
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein.
    Warner AA, Pettenati MJ, Burton BK.
    Obstet Gynecol; 1990 Jan; 75(1):64-6. PubMed ID: 1688649
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Congenital nephrosis as a cause of elevated alpha-fetoprotein.
    Albright SG, Warner AA, Seeds JW, Burton BK.
    Obstet Gynecol; 1990 Nov; 76(5 Pt 2):969-71. PubMed ID: 1699188
    [Abstract] [Full Text] [Related]

  • 8. Endometrial and fetoplacental markers in pregnancies with fetal congenital nephrosis.
    Heinonen S, Ryynänen M, Kirkinen P, Saarikoski S.
    Acta Obstet Gynecol Scand; 1996 Jul; 75(6):526-30. PubMed ID: 8693927
    [Abstract] [Full Text] [Related]

  • 9. Elevated maternal serum alpha-fetoprotein concentration and fetal chromosomal abnormalities.
    Stiller RJ, de Regt RH, Suntag S, Baumgarten A, Hobbins JC, Mahoney MJ.
    Obstet Gynecol; 1990 Jun; 75(6):994-7. PubMed ID: 1692983
    [Abstract] [Full Text] [Related]

  • 10. AFP and age screening for Down syndrome.
    Wald N, Cuckle H.
    Am J Med Genet; 1988 Sep; 31(1):197-209. PubMed ID: 2464930
    [Abstract] [Full Text] [Related]

  • 11. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ, Gabert HA, Diket AL, St Amant M, Miller JM.
    J Matern Fetal Med; 1998 Sep; 7(6):304-7. PubMed ID: 9848697
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
    Wenstrom KD, Owen J, Davis RO, Brumfield CG.
    Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
    [Abstract] [Full Text] [Related]

  • 13. Antenatal screening for congenital nephrosis in Finland by maternal serum alpha-fetoprotein.
    Ryynänen M, Seppälä M, Kuusela P, Rapola J, Aula P, Seppä A, Jokela V, Castren O.
    Br J Obstet Gynaecol; 1983 May; 90(5):437-42. PubMed ID: 6189511
    [Abstract] [Full Text] [Related]

  • 14. Impact of prenatal mid-trimester screening on the prevalence of fetal structural anomalies: a prospective epidemiological study.
    Papp Z, Tóth-Pál E, Papp C, Tóth Z, Szabó M, Veress L, Török O.
    Ultrasound Obstet Gynecol; 1995 Nov; 6(5):320-6. PubMed ID: 8590201
    [Abstract] [Full Text] [Related]

  • 15. [Genetic heterogeneity and pathology of congenital nephrotic syndrome and its significance in prenatal diagnosis].
    Braga S, Moser H, Zimmermann A, Oetliker O.
    J Genet Hum; 1985 Jun; 33(2):153-6. PubMed ID: 2410560
    [Abstract] [Full Text] [Related]

  • 16. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS, Haverkamp AD, Stark CF, Haverkamp C, Barth CK.
    J Matern Fetal Med; 1996 Jun; 5(2):70-3. PubMed ID: 8796771
    [Abstract] [Full Text] [Related]

  • 17. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
    Schell DL, Drugan A, Brindley BA, Zador IE, Johnson MP, Schwartz DB, Evans MI.
    J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
    [Abstract] [Full Text] [Related]

  • 18. Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction.
    Grau P, Robinson L, Tabsh K, Crandall BF.
    Obstet Gynecol; 1990 Dec; 76(6):1042-5. PubMed ID: 1700349
    [Abstract] [Full Text] [Related]

  • 19. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A, Alpert E, Neff RK, Frigoletto FD.
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [Abstract] [Full Text] [Related]

  • 20. Early pregnancy screening for neural tube defects in Israel.
    Legum C, Shomrat R, Yedwab G, Jaffa AJ, Rudick A.
    Isr J Med Sci; 1986 Jan; 22(3-4):210-4. PubMed ID: 2427475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.